跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
溴莫尼定噻吗洛尔滴眼液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Brimonidine Tartrate and Timolol Maleate Eye Drops
Approved
化学药品
Brimonidine Tartrate and Timolol Maleate Eye Drops
AbbVie Limited
🇨🇳 National Medical Products Administration
Approval Date
Oct 29, 2024
Approval ID
8fOMsIRsndf
Company
AbbVie Limited
Type
化学药品
Approval Details
Approval Id
8fOMsIRsndf
Approval Number
国药准字HJ20140928
Generic Name
溴莫尼定噻吗洛尔滴眼液
Generic Name En
Brimonidine Tartrate and Timolol Maleate Eye Drops
Drug Type
化学药品
Dosage Form
滴眼剂
Strength
5ml:酒石酸溴莫尼定10.0mg和马来酸噻吗洛尔25.0mg(以噻吗洛尔计)
Reg Date
2024-10-29
Expired Date
2029-10-28
Company Name
AbbVie Limited
Production Company Name
Allergan Pharmaceuticals Ireland
Company Detail Path
/organization/abbvie-limited
Production Company Detail Path
/organization/allergan-pharmaceuticals-ireland
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 29, 2024
Approval ID
8fOMsIRsndf
Type
化学药品
Back to NMPA Approvals